NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/16/2024
Back to search
Official data from USPTO
RECLAST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
09/16/2024
Trademark type
Word
Nice classes
5
Filing date
08/08/2002
Registration date
10/19/2004
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/16/2024
Last transaction
09/16/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
1
Owner type
03
Owner location
BASEL, CH
Examiner
SHANAHAN, PATRICK
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SANDOZ AG
Novartis AG
Representatives
Maury M. Tepper, III TEPPER & EYSTER, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the preventions and/or treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe respiratory systemthe musculo-skeletal systemthe genitourinary systemfor the treatment of inflammatory disordersfor use in dermatologyin oncologyin ophthalmologyfor use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases
Publications
History of USPTO decisions and trademark events.
41 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
09/16/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/16/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/16/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
07/01/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/06/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/19/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/24/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/24/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/24/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/24/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
09/15/2014
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
07/20/2012
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
07/20/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/19/2012
E15R
TEAS SECTION 15 RECEIVED
07/18/2012
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
10/22/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/18/2010
ES8R
TEAS SECTION 8 RECEIVED
10/15/2010
CORV
REVIEW OF CORRESPONDENCE COMPLETE
12/14/2009
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/14/2009
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/26/2009
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/19/2004
PAPER RECEIVED
12/06/2004
R.PR
REGISTERED-PRINCIPAL REGISTER
10/19/2004
PUBO
PUBLISHED FOR OPPOSITION
07/27/2004
NPUB
NOTICE OF PUBLICATION
07/07/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/04/2004
EMRV
EMAIL RECEIVED
03/18/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/17/2004
CNRT
NON-FINAL ACTION MAILED
01/30/2004
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/30/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/06/2003
CFIT
CASE FILE IN TICRS
10/27/2003
CNSI
INQUIRY AS TO SUSPENSION MAILED
10/14/2003
1.BD
Sec. 1(B) CLAIM DELETED
09/26/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/26/2003
PAPER RECEIVED
09/26/2003
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/09/2003
GNSL
LETTER OF SUSPENSION E-MAILED
01/13/2003
DOCK
ASSIGNED TO EXAMINER
01/07/2003
Continuous trademark protection
Get notified about every new filing that threatens RECLAST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.